key events this year:
ASX listing by end October
Rosehip supplier acquisition
Capital raising
(All things we know)
Printable View
key events this year:
ASX listing by end October
Rosehip supplier acquisition
Capital raising
(All things we know)
FY16 will always be considered a stand out year
The revenue from distribution (CS&co acquisition) is worth more than revenue from Ecoya
New Rosehip range released in October.
Driving more market share in NZ and Australia via distribution.
China and Korea are key markets, but can't be registered in China as they require animal testing but TIL are against this. Partnering with a company that can help with sales in this area.
They want to own the new Chia seed market, just as they do with Rosehip.
That's a good focus, I feel.
little bit disappoint about the F17 guidance. my own estimates was 117m.
F17 100~110m means if we exclude CS&Co there is not much growth left..
AGM stuff: https://nzx.com/companies/TIL/announcements/289571
Forecasts: https://nzx.com/companies/TIL/announcements/289572
to complement the live streaming from our reporter at the scene.
Best Wishes
Paper Tiger
Hope market isn't as disappointed with that guidance as I am
Ecoya: focus on limited edition ranges to grow seasonal sales. Last years Christmas range contributed 10% of total revenue.
Yep market not liking the outlook let's hope they have undercooked the growth figures again
Sustainability:
Community empowerment programs in Kenya, women's empowerment UN principles program, and also achieved carbon neutrality this year. 15% decrease target over next 5 years.
Unfortunately, I'm not surprised to see this kind of "extremely average" guidance, combined with a "dramatic" drop in sales growth... trading at a forward PE of 16 (suppose this isn't to bad...), but with growth clearly slowing (profit might not even rise 20% in the coming year...), it is very hard to see how TIL's share price could rise from its already "lofty" highs... and keep an eye on that debt
I see the share price is now reacting accordingly
Half year guidance: $47.5m, 62% increase
Full year guidance: $100-$110m, 20-32% increase
Milestone target to reach $100m
Offered at $ 4.00 , what are they saying there ?
Question about diversity of the board. Not entirely sure if the meant gender? I wouldn't have thought it's a problem. Maybe referring to ethnicity? Unclear question, but sensible answer that diversity is constantly reviewed.